Suscribirse

Mobility and satisfaction with a microprocessor-controlled knee in moderately active amputees: A multi-centric randomized crossover trial - 29/08/18

Doi : 10.1016/j.rehab.2018.04.003 
Céline Lansade a, , Eric Vicaut b, Jean Paysant c, Doménico Ménager a, Marie-Christine Cristina d, Frank Braatz e, Stephan Domayer f, Dominic Pérennou g, Gérard Chiesa a
a Institut Robert-Merle d’Aubigné, 2, rue Emilion-Michaut et Lucien-Rabeux, 94460 Valenton, France 
b Clinical Trial Unit of Lariboisière Hospital, Medial Device Evaluation Center, France 
c Institut régional de médecine physique et de réadaptation, 75, boulevard Lobau, 54042 Nancy, France 
d Pôle Saint-Hélier, 54, rue Saint-Hélier, CS 74330, 35043 Rennes, France 
e Universitätsmedizin Göttingen, Robert-Koch Strasse 40, 37075 Göttingen, Germany 
f Sonderkrankenanstalt Zicksee, Otto Pohanka Platz, 7161 Sankt Andrä am Zicksee, Austria 
g Hôpital Sud, CHU de Grenoble, BP 338, avenue de Kimberley, 38434 Echirolles, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

With the Kenevo microprocessor-controlled knee (MPK) for moderately active amputees, the Timed Up and Go score was shorter than with non-MPKs (NMPKs). The global score of the locomotor capacity index was significantly improved with the MPK.
Global satisfaction was significantly improved with the MPK versus the NMPK.
MPKs explicitly tailored to the specific needs of this vulnerable population should be considered as a viable therapeutic option to increase mobility and participation.

El texto completo de este artículo está disponible en PDF.

Abstract

Objective

Microprocessor-controlled knees are generally prescribed and reimbursed for active amputees. Recent studies suggested that this technology could be useful for amputees with moderate activity level. We compared the efficiency of a microprocessor-controlled knee (MPK, Kenevo, Otto Bock) and non-MPKs (NMPKs) in these indications.

Methods

A multi-centric randomized crossover trial was conducted in 16 hospitals from 3 European countries. Participants were randomized to an MPK-NMPK sequence, testing the MPK for 3 months and the NMPK for 1 month, or to an NMPK-MPK sequence, testing the NMPK for 1 month and the MPK for 3 months. Dynamic balance, the main criteria, was assessed with the Timed-Up and Go test (TUG), functional mobility with the Locomotor Capability Index (LCI-5), quality of life with the Medical Outcomes Study Short Form 36 v2 (SF-36v2) and satisfaction with the Quebec User Evaluation of Satisfaction with Assistive Technology 2.0. The occurrence of falls was monitored during the last month of trial. Analysis was by intent-to-treat and per-protocol (PP).

Results

We recruited 35 individuals with transfemoral amputation or knee disarticulation (27 males; mean age 65.6years [SD 10.1]). On PP analysis, dynamic balance and functional mobility were improved with the MPK, as shown by a reduced median TUG time (from 21.4s [Q1–Q3 19.3–26.6] to 17.9s [15.4–22.7], P=0.001) and higher mean global LCI-5 (from 40.4 [SD 7.6] to 42.8 [6.2], P=0.02). Median global satisfaction score increased (from 3.9 [Q1–Q3 3.8–4.4] to 4.7 [4.1–4.9], P=0.001) and quality of life was improved for the mental component summary of the SF-36v2 (median score from 53.3 [Q1–Q3 47.8–60.7] to 60.2 [51.6–62.6], P=0.03) and physical component summary but not significantly (mean score from 44.1 [SD 6.3] to 46.3 [7.0], P=0.08). Monitoring of adverse events including falls revealed no differences between both assessed devices.

Conclusion

This study enhances the level of evidence to argue equal opportunity for all individuals with transfemoral amputation or knee disarticulation, regardless of their mobility grade, to be provided with appropriate prostheses.

El texto completo de este artículo está disponible en PDF.

Keywords : Amputation, Balance, Mobility, Multi-centric, Randomized, Crossover


Esquema


© 2018  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 61 - N° 5

P. 278-285 - septembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • Assessment of innovation in prosthetic fitting for transfemoral amputees: A model for asking basic questions of physical and rehabilitation medicine?
  • Jean-Marie Casillas
| Artículo siguiente Artículo siguiente
  • Effect of single-session dual-tDCS before physical therapy on lower-limb performance in sub-acute stroke patients: A randomized sham-controlled crossover study
  • Wanalee Klomjai, Benchaporn Aneksan, Anuchai Pheungphrarattanatrai, Thanwarat Chantanachai, Nattha Choowong, Soontaree Bunleukhet, Paradee Auvichayapat, Yongchai Nilanon, Vimonwan Hiengkaew

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.